Callan Capital’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$730K Buy
4,065
+476
+13% +$89.1K 0.05% 154
2024
Q4
$673K Buy
3,589
+301
+9% +$60.2K 0.05% 139
2024
Q3
$679K Buy
3,288
+277
+9% +$55.7K 0.05% 144
2024
Q2
$586K Buy
3,011
+727
+32% +$134K 0.05% 144
2024
Q1
$398K Buy
2,284
+185
+9% +$30.9K 0.04% 168
2023
Q4
$358K Sell
2,099
-132
-6% -$20.5K 0.03% 159
2023
Q3
$355K Buy
2,231
+132
+6% +$22.5K 0.04% 144
2023
Q2
$378K Hold
2,099
0.04% 126
2023
Q1
$390K Hold
2,099
0.05% 125
2022
Q4
$347K Hold
2,099
0.04% 127
2022
Q3
$325K Hold
2,099
0.05% 101
2022
Q2
$323K Hold
2,099
0.05% 91
2022
Q1
$385K Sell
2,099
-153
-7% -$27K 0.05% 91
2021
Q4
$424K Buy
2,252
+212
+10% +$40.7K 0.06% 81
2021
Q3
$392K Hold
2,040
0.07% 72
2021
Q2
$392K Hold
2,040
0.07% 71
2021
Q1
$386K Hold
2,040
0.07% 70
2020
Q4
$335K Buy
2,040
+104
+5% +$16.2K 0.07% 71
2020
Q3
$276K Sell
1,936
-192
-9% -$26.1K 0.06% 73
2020
Q2
$270K Hold
2,128
0.07% 79
2020
Q1
$213K Buy
+2,128
New +$255K 0.07% 75

Other funds holding TXN

Callan Capital's TXN Position: Q1 2025 in Review

Callan Capital increased its Texas Instruments (TXN) stake by 13% in Q1 2025, buying an estimated $89.1K and bringing the position to 4,065 shares worth $730K. The position accounts for 0.05% of the portfolio, ranked #154.

Callan Capital first reported a position in TXN in Q1 2020 and has held it in 21 quarters since. 2,365 funds tracked by Wall St. Rank hold TXN as of Q1 2025.

  • Callan Capital held 4,065 shares of Texas Instruments worth $730K as of Q1 2025.
  • Callan Capital bought 476 Texas Instruments shares in Q1 2025, an estimated $89.1K.
  • Texas Instruments made up 0.05% of Callan Capital's portfolio in Q1 2025, its #154 holding.
  • Callan Capital first reported a position in Texas Instruments in Q1 2020 and has held it in 21 quarters since.
  • 2,365 funds tracked by Wall St. Rank held Texas Instruments as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.